Eptifibatide 0.75mg/mL Infusion: Comprehensive Medicine Guide
When to Call Your Doctor IMMEDIATELY
- Severe or uncontrollable bleeding from any site
- Blood in urine or stool
- Sudden severe headache, confusion, or weakness
- Difficulty breathing or chest pain
- Swelling of face, lips, or throat
- Decreased urine output
- Unusual bruising or petechiae
If experiencing severe symptoms, call emergency services immediately.
What is eptibind 0.75mg/ml infusion used for?
Eptifibatide infusion is a potent antiplatelet medicine given intravenously in hospitals to prevent blood clots in patients with acute coronary syndrome or those undergoing percutaneous coronary intervention (PCI). It works by blocking the glycoprotein IIb/IIIa receptor on platelets, reducing the risk of heart attack and other thrombotic complications.
- Generic Name: Eptifibatide (0.75mg/ml)
- Manufacturer: Torrent Pharmaceuticals Ltd
- Form: Allopathy
- Pregnancy Category: Consult doctor
- Prescription Required: Yes
🇮🇳 eptibind 0.75mg/ml infusion के बारे में (Hindi Summary)
उपयोग: यह दवा एक इंट्रावेनस इन्फ्यूजन है जिसमें एप्टीफिबेटाइड 0.75 मिलीग्राम/मिलीलीटर होता है। यह एक शक्तिशाली एंटीप्लेटलेट दवा है जिसका उपयोग अस्पताल में उन रोगियों में रक्त के थक्के बनने से रोकने के लिए किया जाता है जिन्हें तीव्र कोरोनरी सिंड्रोम (अस्थिर एनजाइना या दिल का दौरा) है या जिनकी पर्क्यूटेनियस कोरोनरी इंटरवेंशन (पीसीआई) की जा रही है। यह दवा प्लेटलेट्स पर जीपी IIb/IIIa रिसेप्टर को ब्लॉक करके काम करती है, जिससे रक्त के थक्के नहीं बन पाते। यह दवा केवल डॉक्टर की देखरेख में अस्पताल में ही दी जाती है।
साइड इफेक्ट्स: इस दवा का सबसे आम दुष्प्रभाव रक्तस्राव है, जो इन्फ्यूजन साइट पर या शरीर में कहीं और हो सकता है। मरीजों को हल्की चोट, नाक से खून आना, या मसूड़ों से खून आना हो सकता है। गंभीर रक्तस्राव जैसे पेट या मस्तिष्क में रक्तस्राव दुर्लभ है लेकिन जानलेवा हो सकता है। अन्य दुष्प्रभावों में कम रक्तचाप, मतली और सिरदर्द शामिल हैं। एलर्जी की प्रतिक्रिया कम होती है लेकिन संभव है।
सुरक्षा सलाह: यह दवा केवल अस्पताल या क्लिनिक में डॉक्टर की देखरेख में दी जाती है। आपको इसे स्वयं नहीं देना चाहिए। इस दवा को लेने से पहले अपने डॉक्टर को अपनी सभी चिकित्सीय स्थितियों के बारे में बताएं, विशेष रूप से रक्तस्राव विकार, हाल की सर्जरी, या यदि आप गर्भवती या स्तनपान करा रही हैं। इसके अलावा, अपने डॉक्टर को आपके द्वारा ली जा रही सभी अन्य दवाओं के बारे में बताएं। इन्फ्यूजन के दौरान, किसी भी असामान्य रक्तस्राव, चोट या परेशानी की तुरंत चिकित्सा कर्मचारियों को सूचना दें।
💊 eptibind 0.75mg/ml infusion Uses & Benefits
[{"condition":"Acute Coronary Syndrome (Unstable Angina/Non-ST-Elevation Myocardial Infarction)","description":"Used to prevent blood clots in patients with unstable angina or non-ST-elevation myocardial infarction, often in combination with aspirin and heparin.","evidence":"Well-established"},{"condition":"Percutaneous Coronary Intervention (PCI)","description":"Administered during PCI with stenting to reduce the risk of thrombotic complications.","evidence":"Well-established"}]
Off-label uses: [{"condition":"ST-Elevation Myocardial Infarction (STEMI) undergoing primary PCI","description":"Sometimes used off-label as an adjunct to primary PCI in STEMI patients, though evidence is mixed.","evidence":"Limited"}]
Primary treatment for: Acute Coronary Syndrome
Also treats: Unstable Angina, Non-ST-Elevation Myocardial Infarction
📋 Drug Information
| Generic Name(s) | Eptifibatide (0.75mg/ml) |
| Brand Name | eptibind 0.75mg/ml infusion |
| Manufacturer | Torrent Pharmaceuticals Ltd |
| Packaging / Form | Varies by brand (Allopathy) |
| Therapeutic Class | BLOOD RELATED |
| Action Class | Glycoprotein IIb/IIIa inhibitors |
| Route of Administration | Parenteral (intravenous infusion) |
| Storage | Store at 2°C to 8°C (36°F to 46°F). Do not freeze. Protect from light. |
| Shelf Life | Not established from the available information. |
| WHO Guideline | Not established from the available information. |
| ICMR Guideline | Not established from the available information. |
👨⚕️ Doctor's Practical Tips
Evidence-based practical advice from experienced clinicians
🔍 Is This Medicine Right for Your Symptom?
Educational reference. Always consult a doctor for diagnosis.
🔬 How This Medicine Works (Pharmacology)
Pharmacokinetics
How It Works
Eptifibatide is a synthetic cyclic heptapeptide that reversibly binds to the glycoprotein IIb/IIIa receptor on the surface of activated platelets. By occupying this receptor, it prevents fibrinogen and von Willebrand factor from binding, thereby blocking the final common pathway of platelet aggregation. This action inhibits the formation of blood clots and reduces the risk of ischemic complications in acute coronary syndromes and during percutaneous coronary intervention.
Mechanism Steps
💡 How to Take eptibind 0.75mg/ml infusion
Strength: 0.75 mg/mL infusion
Dosage Information
| Adult Dosage | The dose of this medicine is individualized by a qualified clinician based on the patient's condition, weight, and renal function. For acute coronary syndrome, a common regimen is an intravenous bolus of 180 mcg/kg followed by a continuous infusion of 2 mcg/kg/min for up to 72 hours. For percutaneous coronary intervention, a similar regimen may be used. Dose must be individualized by a qualified clinician based on indication, age, weight, renal and hepatic function. |
| Pediatric Dosage | Pediatric dosing is not established from available information. Consult a pediatrician. |
| Elderly Dosage | Elderly patients may be at increased risk of bleeding. Dose should be individualized by a qualified clinician based on renal function and overall health status. |
| Renal Impairment | In patients with renal impairment (creatinine clearance <50 mL/min), the infusion rate should be reduced. For creatinine clearance <30 mL/min, use is contraindicated. Dose must be individualized by a qualified clinician. |
| Hepatic Impairment | Not established from the available information. Use with caution in patients with hepatic impairment. |
| Maximum Daily Dose | Not established from the available information. Dosing is individualized by a qualified clinician. |
Dosage Timeline
⏰ What to Do If You Miss a Dose
⚠️ Side Effects of eptibind 0.75mg/ml infusion
✅ Common Side Effects
🚨 Serious Side Effects
⚠️ Rare Side Effects
Consult your doctor if you experience any unusual symptoms.
🔬 Drug Interactions
| Drug | Severity | Effect |
|---|---|---|
| Warfarin | Major | |
| Heparin | Major | |
| Aspirin | Major | |
| Clopidogrel | Major | |
| Alteplase | Major | |
| Ibuprofen | Moderate | |
| Naproxen | Moderate | |
| Dipyridamole | Moderate | |
| Ginkgo biloba | Minor | |
| Garlic | Minor |
🚨 Major Interactions
- Anticoagulants (e.g., warfarin, heparin)
- Thrombolytic agents (e.g., alteplase)
- Other antiplatelet agents (e.g., aspirin, clopidogrel)
⚡ Moderate Interactions
- NSAIDs (e.g., ibuprofen, naproxen)
- Dipyridamole
🍷 Alcohol Interaction
Alcohol may increase the risk of bleeding and should be avoided during treatment with this medicine.
🔎 Check Your Other Medicines
Educational tool. Always confirm with your doctor or pharmacist.
🛡️ Safety & Warnings
🚫 Contraindications
["Active bleeding","History of bleeding diathesis","Severe uncontrolled hypertension","Recent stroke (within 30 days)","Major surgery within 6 weeks","Severe renal impairment (creatinine clearance
⚠️ Warnings & Precautions
["This medicine should be used only by healthcare professionals in a hospital setting.","Monitor closely for signs of bleeding.","Use with caution in patients with renal impairment; dose adjustment may be needed.","Avoid concomitant use with other drugs that increase bleeding risk unless necessary.","Thrombocytopenia has been reported; monitor platelet counts.","Not for use in patients with a history of bleeding disorders."]
🤱 Lactation Safety
Not established from the available information. Consult your doctor before breastfeeding.
💊 Overdose Management
Overdose may lead to severe bleeding. There is no specific antidote. Treatment is supportive. Platelet transfusion may be considered. Discontinue infusion immediately and manage bleeding as appropriate.
⏰ Missed Dose
This medicine is given as a continuous infusion in a hospital setting. Missed doses are not applicable as it is administered by healthcare professionals.
Additional Safety Advice
This medicine is given only in a hospital or clinic under the supervision of a doctor. You should not attempt to administer it yourself. Before receiving this medicine, tell your doctor about all your medical conditions, especially any bleeding disorders, recent surgeries, or if you are pregnant or breastfeeding. Also, inform your doctor about all other medicines you are taking, including blood thinners, NSAIDs, and herbal supplements. During the infusion, report any unusual bleeding, bruising, or discomfort immediately to the medical staff. After the infusion, follow your doctor's instructions carefully and keep all follow-up appointments.
👴 Special Considerations for Elderly
💡 For Patients Above 65
Elderly patients are at higher risk of bleeding. Dose should be adjusted based on renal function. Close monitoring is required.
🤰 Pregnancy Planning (TTC)
Not established from the available information. Consult your doctor if you are planning pregnancy or are pregnant.
🏥 Post-Surgery Considerations
This medicine is contraindicated in patients who have had major surgery within 6 weeks due to increased bleeding risk.
🦷 Dental Procedures
Inform your dentist if you have recently received this medicine, as it may increase bleeding risk during dental procedures.
💚 Lifestyle Tips for Better Results
🏋️ Exercise Considerations
Avoid strenuous activities or contact sports that could increase the risk of bleeding while on this medicine. Follow your doctor's advice on when to resume exercise.
🥗 Diet Recommendations
💼 Impact on Daily Work & Life
This medicine is given in a hospital, so it does not directly impact daily work. After discharge, you may need to take time off to recover. Avoid driving or operating machinery until cleared by your doctor, especially if you experience dizziness or bleeding.
🛑 When to Stop This Medicine
This medicine is stopped by healthcare professionals after the prescribed duration or if serious bleeding occurs. Do not stop any other medications without consulting your doctor.
📅 Long-Term Use Effects
Eptifibatide is typically used for short durations (up to 72 hours) in hospital settings. Long-term effects are not well established. Patients should be monitored for bleeding and thrombocytopenia during and after infusion. Follow-up with a cardiologist is essential to manage underlying heart disease.
🌿 Non-Medicine Approaches
These can complement medicine but do not replace prescribed treatment.
Another GP IIb/IIIa inhibitor that can be used as an alternative.
Evidence: Well-establishedAnother GP IIb/IIIa inhibitor, but with different dosing and duration.
Evidence: Well-established💉 Vaccination Considerations
💉 If You're Getting Vaccinated
Not established from the available information. Consult your doctor regarding vaccinations while on this medicine.
📦 Storage Guide
✅ DO
Store in a refrigerator at 2°C to 8°C.
❌ DON'T
Do not freeze.
✅ DO
Protect from light.
❌ DON'T
Do not use if the solution is discolored or contains particles.
✅ DO
Keep in original packaging.
❌ DON'T
Do not store at room temperature for extended periods.
✈️ Traveling with This Medicine
This medicine is administered only in a hospital setting, so travel advice is not applicable. If you are traveling after receiving this medicine, carry a copy of your prescription and medical records. Inform your doctor before any travel, especially if you are on other blood thinners. Keep all follow-up appointments.
💰 Cost Analysis & Savings
👥 Real Patient Stories
Educational, anonymized scenarios. Individual results may vary.
💬 Questions Patients Often Ask
A: Eptifibatide starts working within minutes after intravenous administration, inhibiting platelet aggregation rapidly.
A: It is given as an intravenous bolus followed by a continuous infusion in a hospital setting.
A: The most common side effect is bleeding, which can occur at the infusion site or elsewhere. Other side effects include nausea and headache.
A: Patients with active bleeding, severe uncontrolled hypertension, recent stroke, or severe renal impairment should not receive this medicine.
🤔 Common Patient Concerns
🔄 Substitutes for eptibind 0.75mg/ml infusion
View AllAlternative brands with exact same active ingredient:
-
eptide 0.75mg/ml infusionSun Pharmaceutical Industries Ltd ₹8,148.42 4.1% CHEAPER
-
eptiflo 0.75mg/ml infusionSun Pharmaceutical Industries Ltd ₹8,371.42 1.5% CHEAPER
-
clotide 0.75mg/ml infusionBiocon ₹8,500.00 SAME PRICE
-
eptiba infusionIntas Pharmaceuticals Ltd ₹8,500.00 SAME PRICE
-
Fleta 0.75mg/ml InfusionLupin Ltd ₹8,500.00 SAME PRICE
Medical Note: Always consult your doctor before switching medications.
🛑 Myths vs. Facts
- Myth: Eptifibatide can be taken at home.
Fact: Eptifibatide is given only in a hospital setting under close supervision. - Myth: Eptifibatide is a pain reliever.
Fact: Eptifibatide is an antiplatelet medicine used to prevent blood clots, not to relieve pain.